Ascend Wellness Holdings (AAWH) Other Accumulated Expenses (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Other Accumulated Expenses of $9.0 million for Q1 2026, up 73.1% year-over-year from $5.2 million in Q1 2025, and up 27.41% quarter-over-quarter from $7.1 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 73.1% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (up 73.1% YoY), while the FY2025 annual figure was $7.1 million, up 39.72% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $9.0 million, up from $7.1 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $9.0 million in Q1 2026, with the low at $4.1 million in Q1 2022.
- The 5-year median for Other Accumulated Expenses is $5.5 million (2023), against an average of $5.9 million.
- The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses fell 29.4% in 2025, then jumped 73.1% in 2026.
- Ascend Wellness Holdings' Other Accumulated Expenses stood at $5.7 million in 2022, then increased by 18.41% to $6.8 million in 2023, then declined by 25.21% to $5.1 million in 2024, then jumped by 39.72% to $7.1 million in 2025, then advanced by 27.41% to $9.0 million in 2026.
- Business Quant data shows AAWH's Other Accumulated Expenses at $9.0 million in Q1 2026, $7.1 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Ascend Wellness Holdings | 86.08 Mn | 19.08 Mn | 45.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.76 Mn |
| Mar 31, 2026 | 9.01 Mn |
| Dec 31, 2025 | 7.07 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 5.06 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 7.37 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 5.53 Mn |
| Mar 31, 2023 | 4.55 Mn |
| Dec 31, 2022 | 5.71 Mn |
| Sep 30, 2022 | 4.50 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 4.05 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 4.99 Mn |